NYU Langone Medical Center researchers have discovered a possible new drug target for treating childhood cancer. T-cell acute lymphoblastic leukemia is one of the most common and aggressive childhood blood cancers. An estimated quarter of the 500 adolescents and young adults diagnosed with the cancer each year in the U.S. fail to achieve remission with standard chemotherapy drugs. In a cover-story report set to appear in the journal iCell/i online ...
Read More
No comments:
Post a Comment